To all interested in ID and #idtwitter, we have multiple spots open at UMass Chan - Division of Infectious Diseases for fellowship starting in July 2024. Come work with me and a great group of ID docs with a challenging and diverse patient population. Also your 2nd year fellows are going to be a great group!!

Welcome new ID fellows!!! #MatchDay #infectiousdisease #IDTwitter #FellowshipMatch

Excellent table!

This was a lot of fun to discuss! Thank you so much @swinndong!

Dalbavancin non inferior to (North America) SOC in complicated SAB/RSE when randomised after c7 days of standard IV initial Rx - Nicholas Turner #ESCMIDGlobal2024

🆕️🔥Systematic Review Clinical Infectious Diseases Breakthrough Invasive Fungal Infections in Patients With High-Risk Hematological Disorders Receiving Voriconazole and Posaconazole Prophylaxis #idxposts academic.oup.com/cid/article/do…

What an incredible feeling to present my first #ASCO24 talk ever! Grateful for the opportunity! Hem malignancy highlights from Day 1: UW Health | Carbone Cancer Center UW Hematology-Oncology and Palliative Care University of Wisconsin Department of Medicine Women in Lymphoma - [email protected]

Long-term outcomes of adjunctive lung resection for nontuberculous mycobacteria pulmonary disease ✅ Just Accepted 🔗 bit.ly/3L4EwPq

Swapnil Lanjewar, MD (Swapnil Lanjewar, MD, FACP), clinical assistant professor, UW-Madison Division of Infectious Disease, was selected to serve on the American Board of Internal Medicine (ABIM) Infectious Disease Item-Writing Task Force for the 2024-2026 term. Congratulations, Dr. Lanjewar!

Pulmonary infections according to types of immunosuppression

Thank you Congressman Raul Ruiz, M.D. for your leadership.

📣📣 Trainee Poster! Michael Scolarici of UW-Madison Division of Infectious Disease presenting a Comprehensive Survey of Current Transplant Infectious Diseases Fellowship Programs at #IDWeek2024 IDWeek

It was a wonderful experience to finally meet the members of #SouthAsiansInID #SAID at IDWeek! Thank you so much @freeradhikal for creating this group and Priya Nori MD, FSHEA, FIDSA Sidd Kogilwaimath MD MPH for promoting it! IDSA

Finally! We have an US FDA approved oral carbapenem-Sulopenem! BUT… Looks like it’s only for uncomplicated UTIs. It is not good enough for complicated UTIs or intra-abdominal infections.

RFK Jr. went on national TV and spouted egregious, dangerous falsehoods about vaccines. As a parent and infectious diseases doctor, I couldn't stay silent. Fox News might not fact-check him, but I will. I've reviewed the trials. I've catalogued them. I have receipts. 🧵